April 15, 2014 | Health Matters

Michael Lucas takes on AHF president over Truvada claims

TruvedaPorn star and producer Michael Lucas is not at all happy that the president of the AIDS Healthcare Foundation (AHF) has likened Truvada to party drugs.
 
Truvada is the drug individuals take daily as a preventative measure against contracting HIV. The measure is often referred to as Pre-Exposure Prophylaxis, or PrEP for short.
 
Michael Weinstein, president of the AHF, isn't a fan. "Let’s be honest: It’s a party drug,” he told the Associated Press, claiming men are using it to justify unprotected sex.
 
He also told ABC News: “I think it will be a catastrophe for HIV prevention in this country,”
 
Lucas countered, in an editorial for OUT, "It would be one thing if this were a talking point of a crackpot on The 700 Club," "Hell, Mr. Weinstein’s words could be adapted nicely for a poster for the Westboro Baptist Church. But this man, who earns, according the LA Times, around $390,000 per year, leads an organization that’s the largest provider of HIV/AIDS services in the United States. Yet his views are so out of line with scientific reality that, before approving PrEP, the head of the Centers for Disease Control refused to even meet with him."
 
Lucas then pointed to research that indicated the program is at least 90 percent effective, with no reported cases of someone becoming HIV+ while on PrEP. "We need to take Mr. Weinstein and his radical rhetoric out of the national conversation," Lucas suggested. "He needs to be removed from his post at the AIDS Healthcare Foundation. Immediately."
 
Weinstein is somewhat of a drama queen and should, at the very least, approach Truvada with a more tempered skepticism. Lucas, of course, has his own bias as a user of the PrEP method. It's a new drug and it always takes time to see what the real effects, medically and socially, will be. 

Top | Home | About Us | Contact Us | Reviews | Galleries | News | What's Up?

BananaGuide: the gay man's guide to porn
© 2000, 2024 Untangled Web Inc.